Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | -4.90% | 58.57 | 0.0% | $906.01m | |
| AMGN | Amgen, Inc. | 1.22% | 258.24 | 1.3% | $750.82m | |
| GILD | Gilead Sciences, Inc. | 0.38% | 76.35 | 1.0% | $724.94m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 2.18% | 622.45 | 2.5% | $659.43m | |
| NVAX | Novavax, Inc. | 2.43% | 81.64 | 102.0% | $580.82m | |
| BIIB | Biogen, Inc. | 0.13% | 265.12 | 1.6% | $559.05m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 1.68% | 291.10 | 1.9% | $527.74m | |
| ILMN | Illumina, Inc. | 1.24% | 373.10 | 3.5% | $308.62m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.08% | 112.30 | 2.0% | $228.46m | |
| BMRN | BioMarin Pharmaceutical, Inc. | 0.75% | 126.78 | 4.3% | $214.78m | |
| SGEN | Seattle Genetics, Inc. | 0.90% | 169.03 | 6.1% | $202.30m | |
| SRNE | Sorrento Therapeutics, Inc. | -1.15% | 6.85 | 1.8% | $184.40m | |
| SRPT | Sarepta Therapeutics, Inc. | -1.77% | 162.75 | 13.9% | $167.23m | |
| INCY | Incyte Corp. | 3.72% | 106.47 | 2.5% | $163.35m | |
| IMMU | Immunomedics, Inc. | 1.71% | 37.54 | 11.0% | $159.56m |
Company Profile
Mirati Therapeutics, Inc. is a clinical-stage oncology company. The firm engages in developing a pipeline of oncology products to treat genetic, immunological and epigenetic drivers of cancer in subsets of cancer patients. Its clinical pipeline consists of glesatinib, sitravatinib and mocetinostat. The company was founded on December 13, 1995 and is headquartered in San Diego, CA.